Robust measurement of vitamin A status in plasma and blood dried on paper by Huang, Y. et al.
ACCEPTED VERSION 
 
Yichao Huang,Peter Roy Clements,Robert Alan Gibson 
Robust measurement of vitamin A status in plasma and blood dried on paper 
Prostaglandins, Leukotrienes and Essential Fatty Acids, 2015; 102-103:31-36 
 
 
© 2015 Elsevier Ltd. All rights reserved. 
This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 


























Authors can share their accepted manuscript: 
[…] 
After the embargo period 
 via non-commercial hosting platforms such as their institutional repository 
 via commercial sites with which Elsevier has an agreement 
In all cases accepted manuscripts should: 
 link to the formal publication via its DOI 
 bear a CC-BY-NC-ND license – this is easy to do, click here to find out how 
 if aggregated with other manuscripts, for example in a repository or other site, be 
shared in alignment with our hosting policy 
 not be added to or enhanced in any way to appear more like, or to substitute for, 
the published journal article 
 
7 Mar, 2016 
1 
 
Robust measurement of vitamin A status in plasma and blood 1 
dried on paper  2 
Yichao Huang, Peter Roy Clements, and Robert Alan Gibson* 3 
 4 
FOODplus Research Centre, School of Agriculture, Food and Wine, the University of Adelaide, 5 
Adelaide, South Australia, Australia 6 
 7 
*To whom correspondence should be addressed: 8 
Prof. Robert A. Gibson 9 
FOODplus Research Centre, School of Agriculture, Food and Wine,  10 
Waite Campus, the University of Adelaide, SA, 5064, Australia 11 
Email: robert.gibson@adelaide.edu.au 12 
Phone: +618 8303 4333 13 
Fax: +618 8303 7135 14 
The project was funded by the NHMRC Centre for Research Excellence “Foods for Future 15 




Vitamin A deficiency is the leading cause of preventable blindness in children and increases 18 
the risk of disease and death from severe infections. In addition, fat soluble vitamin A and 19 
associated retinoids directly regulate the expression of genes involved in fatty acid 20 
metabolism. Conventional methods for measuring vitamin A involve venipuncture, 21 
centrifugation and refrigeration all of which make measuring vitamin A in nutritional surveys 22 
expensive. We aimed to develop a simple and robust system for measurement of retinol 23 
(biomarker for vitamin A) using dried blood spot (DBS) samples. Low recoveries and 24 
inconsistent results reported by others were found to be due to poor extraction efficiency 25 
rather than retinol instability. Maintaining acid conditions during extraction resulted in 26 
recoveries >95% with <6.5% of coefficient of variation. Using isocratic high performance 27 
liquid chromatography, separation was achieved in <3.5 mins. Detector response was linear 28 
(R
2
=0.9939) within a range of 0.05 – 2 μg/mL, with a limit of quantification of 0.05 μg/mL. 29 
Retinol in DBS was shown to be stable (>95%) at room temperature for up to 10 weeks. DBS 30 
values for retinol were highly correlated with venous blood samples from 24 healthy subjects 31 
(r=0.9724) and were consistent with results from a commercial laboratory. This simple and 32 
reliable method for the determination of vitamin A status should prove particularly valuable 33 
for population studies and large clinical trials. 34 
Keywords: 35 
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1. Introduction 38 
Vitamin A is a lipid soluble vitamin that plays important roles in human health including 39 
being an essential component of the photoreceptor rhodopsin, and influences immune 40 
function, reproduction, and bone health. Vitamin A directly regulates the expression of genes 41 
involved in fatty acid metabolism in liver cells, adipocytes, and skeletal muscle [1]. Vitamin 42 
A deficiency can change membrane lipid composition and the activity and gene expression of 43 
the regulatory enzymes associated with fatty acid oxidation in mitochondria [2].  44 
Vitamin A can only be acquired from the diet as either preformed vitamin A (retinol and 45 
retinyl esters) or provitamin A (some carotenoids). Vitamin A deficiency is rare in affluent 46 
countries; however, severe vitamin A deficiency occurs in many developing and undeveloped 47 
countries due to poor nutrition. This is responsible for half a million or more instances of 48 
unnecessary death or blindness each year [3]. On the other hand, the risk of excess vitamin A 49 
intake is higher in developed countries as a result of fortified foods and supplements [4] and 50 
concerns have been expressed about the potential for long term mild vitamin A over 51 
consumption which may result in health problems [5].  52 
Despite the active form being retinoic acids, all-trans retinol is usually used as biomarker to 53 
indicate vitamin A status in blood. Conventional measurement of vitamin A status involves 54 
venipuncture to obtain sufficient blood volume but this creates difficulties for infants, the 55 
elderly and some cultures. Furthermore, most methods require separation of blood cells by 56 
centrifugation and refrigerated transport and storage of samples. This adds substantial cost to 57 
nutritional surveys of populations and large scale clinical trials. Finger prick blood collection 58 
methods using dried blood spots (DBS) have been popularised in many fields including 59 
metabolomics [6]. However, retinol was reported to be unstable in DBS for long term storage 60 
[7, 8]. It was hypothesised that oxidation was responsible for the loss, however pre-treating 61 
the paper medium with antioxidants did not solve the issue [9, 10]. 62 
The aim of the present study was to develop a simple and robust DBS assay of retinol levels 63 
which would allow samples to be stable at room temperature for over 2 months. 64 
2. Materials and Methods 65 
2.1. Solvents and Chemicals 66 
Methanol, HPLC grade, Sigma Aldrich, USA; hexane, ACS reagent, Sigma-Aldrich, USA; 67 
ethanol, HPLC grade, Scharlau, Spain; retinol, Sigma-Aldrich, USA; tocol (internal standard), 68 
Abcam, Cambridge, UK; butylated hydroxytoluene (BHT), Sigma Aldrich, USA; 69 
ethylenediamine-tetraacetic acid disodium salt dehydrate (EDTA) reagent grade, Sigma 70 
Aldrich, USA; NaCl, analytical reagent, Chem-supply, South Australia, Australia; glacial 71 
acetic acid, HPLC grade, APS Ajax Finechem, NSW, Australia. 72 
2.2. Subjects and sampling 73 
The methods for the collection of blood for the study were approved by the Human Research 74 
Ethics Committee, The University of Adelaide, H-2012-087. Participants were given an 75 
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information sheet explaining the nature of the study before signing the Consent Forms. Initial 76 
method development was conducted using blood samples from a single healthy donor with 77 
vitamin A status in the normal range. Twenty-four healthy volunteers were later recruited for 78 
a method validation study. Blood samples from each volunteer included a finger capillary 79 
blood dried (capillary DBS) on 15x30mm 903
®
 filter paper strips  (Whatman, Buckingham, 80 
UK), and a venous blood draw from antecubital veins and collected in vacuum EDTA tubes 81 
(K3EDTA, VACUETTE
®
, Greiner Bio One, Australia). To compare with capillary DBS, 40 82 
μL of the venous blood was spotted on Whatman 903® filter paper (venous DBS) and dried 83 
for 4 h at room temperature. The DBS was sampled using an 8.5 mm punch that 84 
corresponded to a known amount of blood [7]. The remainder of the venous blood sample 85 
was centrifuged and plasma stored at -20°C for later analysis. Dried plasma spots (DPS) were 86 
prepared by pipetting 40 μL aliquots of plasma on to 903® filter paper, drying at room 87 
temperature (≈ 25 °C) for 4 h. 88 
2.3. Estimation of blood volume in DBS 89 
Whatman 903
®
 filter paper is widely used in dried blood spot technology because its porosity 90 
allows for an even distribution of blood on the paper. We found a direct relationship 91 
(R
2
=0.9988) between the volume of whole blood applied to the 8.5 mm circle 903
®
 paper and 92 
dried blood spot weight. This allowed us to calculate that a punch size of 8.5 mm is 93 
gravimetrically equivalent to a whole blood volume of 29.2 ±1.2 μL. 94 
2.4. DBS Method development 95 
The method was initially developed using pooled sample of human plasma that was stored at 96 
-20 °C. Whole blood was subsequently used for method validation. 97 
2.4.1. Effect of pre-treatment of paper with protectant 98 
Experiments were conducted to exclude factors that enhance oxidation including light, 99 
moisture, and oxygen by placing DPS samples in foil bags together with desiccants, and 100 
extracted in amber vials. While this contributed to consistent and reproducible results, retinol 101 
recovery was only 40-60% of that applied (recoveries based on standard methodology [11]). 102 
Attempts were then made to block oxidation by pre-treating Whatman 903
®
 filter paper with 103 
different protectants such as phenolic antioxidants and chelating reagents because they have 104 
been reported to protect unsaturated fatty acids in DBS from oxidation [12]. Thus the 105 
antioxidant BHT (1, 5, 10 mg/mL) and the chelating reagents, EDTA (0.5, 1, 5, 10 mg/mL), 106 
and L-ascorbic acid (1.25, 2.5, 5, 10 mg/mL), were tested individually and in combination. 107 
Plasma samples were spotted onto the pre-treated paper and dried at room temperature (≈ 108 
25 °C) in darkness. Untreated DPS was used as a control. Liquid plasma samples from the 109 
same origin were extracted immediately after thawing and this retinol value was used as the 110 
reference. All samples were processed in triplicate. 111 
2.4.2. Effect of acid on the extraction of retinol from dried plasma spots  112 
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To optimise the best extraction procedure, different organic acid solutions were tested during 113 
retinol extraction from DPS. L-ascorbic acid (1.25, 2.5, 5, 10 mg/mL), oxalic acid (0.1, 0.5, 1, 114 
5, 10 mg/mL), citric acid (0.1, 0.5, 1, 5, 10 mg/mL), and acetic acid (0.06, 0.12, 0.3, 0.6, 3 115 
mg/mL) were tested. Untreated DPS was used as a control. Liquid plasma samples from the 116 
same origin were extracted immediately after thawing and used as the reference. All samples 117 
were processed in triplicate. 118 
2.5. Extraction protocols for plasma and blood samples  119 
Dried plasma spot samples were obtained by applying 40 μL of plasma on to Whatman 903® 120 
paper discs and dried. The disc was placed into a 5 mL amber vial (Phenomenex, Australia), 121 
followed by 0.04 μg internal standard (tocol). The paper disc was submerged in 1 mL 122 
methanol (+/- 2 mM acetic acid) for 10 mins and subjected to intermittent vigorous vortexing 123 
and the solvent collected. The extraction was repeated and the total supernatant methanol 124 
solution was transferred into a fresh amber vial and then dried under nitrogen and finally 125 
reconstituted in 100 μL mobile phase for HPLC analysis. Liquid plasma samples from the 126 
same origin were extracted immediately after thawing and were used as the reference to 127 
calculate recovery. 128 
Dried blood spot samples (≈ 8.5 mm discs) were punched from DBS papers yielding a known 129 
volume (equivalent to 29.2±1.2 μL). The disc was placed in a 5 mL amber vial, with 200 μL 130 
14 mM ascorbic acid aqueous solution and left for 30 mins with intermittent vortexing.  131 
Internal standard (tocol, 0.04 μg) and 400 μL of ethanol were then added. After vortexing, 132 
750 µL of hexane was added. The two phase mixture was vortexed for 5-10 seconds every 5 133 
mins for 15 mins. A 600 μL aliquot of saturated NaCl aqueous solution was added to 134 
facilitate the phase partition, which was also vortexed vigorously for 5-10 seconds at least 2 135 
times before being centrifuged (3000 rpm, 5 mins). The upper phase was collected into a 136 
fresh amber vial. The hexane extraction was repeated and the combined hexane layers were 137 
dried under nitrogen and reconstituted in 100 μL mobile phase for HPLC analysis. Liquid 138 
whole blood samples from the same origin were extracted immediately and used as the 139 
reference. 140 
Plasma/whole blood samples were extracted using a modification of published methods [11, 141 
13] whereby 40 μL of plasma/whole blood samples were deproteinised by addition of 400 μL 142 
ethanol and internal standard in amber vials. After vortexing, 750 µL of hexane was added. 143 
The mixture was vortexed for 5-10 seconds every 5 mins for 15 mins. A 600 μL aliquot of 144 
saturated NaCl solution was then added. The mixture was vortexed vigorously for 5-10 145 
seconds at least 2 times before being centrifuged (3000 rpm, 5 mins). The top phase was 146 
collected into a fresh amber vial. The hexane extraction was repeated and the upper organic 147 
phases were combined and dried under nitrogen, the residue was reconstituted in 100 μL 148 
mobile phase for HPLC analysis. The concentration of retinol in whole blood was calculated 149 
and normalised as per plasma volume using average haematocrit (male 45% erythrocytes, 150 
female 40%) values [14]. 151 
2.6. Stability of retinol in DBS 152 
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Replicate DBS samples were extracted using our optimised method as well as by a previously 153 
published DBS method [15]. Extractions were performed on day 0, 12, 19 and 33 after 154 
spotting. Recoveries of retinol were directly compared between the two methods over time. 155 
Triplicates were used at each time point. 156 
In a more detailed experiment, DBS samples (+/- antioxidant BHT) were stored at room 157 
temperature (≈ 25 °C) in foil bags with desiccants. The DBS samples were extracted on day 0, 158 
3, 7, 14, 28, 42, 56 and 70 to evaluate the stability of retinol in DBS. Triplicates were used at 159 
each time point. 160 
2.7. HPLC conditions 161 
An Agilent HPLC 1260 system with isocratic mobile phase of methanol with 0.05% acetic 162 
acid (HAc) at flow rate 1.5 mL/min, 30 °C, and ZORBAX Eclipse XDB-C18; 4.6 x 150 mm, 163 
5μm column was used. Twenty μL of sample was injected. Retinol and the internal standard 164 
tocol were measured using a diode array detector (DAD) at 325 nm and 292 nm, respectively. 165 
The total run time was 6.5 mins, with retinol and tocol eluting at 1.9 and 3.3 mins, 166 
respectively. 167 
Tocol was used as the internal standard because we found that retinyl acetate, the widely used 168 
internal standard for retinol analysis, was unstable when undergoing extraction. The 169 
instability of retinyl acetate was also reported by Yuan [16]. 170 
2.8. HPLC method comparison 171 
In order to test the accuracy of values acquired from our HPLC quantification, we compared 172 
our values to values obtained in another laboratory (SA Pathology) which offers commercial 173 
services for vitamin analyses, also using an HPLC based method. Retinol concentrations of 174 
plasma from 24 subjects were measured. The linear correlation coefficient showed good 175 
agreement (r=0.9385, p<0.0001) between the two methods. Using a Bland-Altman test, we 176 
found that the differences from the two laboratories were within 96% CI. However, the mean 177 
bias in the test was -7.68%, indicating that our result is systematically slightly higher than the 178 
result from SA Pathology. 179 
2.9. Method validation  180 
A linearity test was conducted by spiking a series of concentrations of retinol standard 181 
solution (0.02, 0.05, 0.1, 0.5, 1, 2 µg/mL) onto 8.5 mm DBS discs and dried with nitrogen in 182 
amber vials for 10 mins prior to extraction. The spiked spots then underwent extraction as per 183 
Section 2.5. Total retinol concentrations were measured and plotted against the corresponding 184 
concentrations of spiked retinol using Microsoft Excel 2010. Additionally, the different 185 
concentrations of retinol standard solutions were also injected directly through HPLC to test 186 
the accuracy of the assay. 187 
For quality control purposes, a set of aliquots of one plasma sample were stored at -20 °C and 188 
measured on different days. Intra-day errors were determined by analysing 6 aliquots of the 189 
sample and inter-day errors were determined by measuring 3 aliquots on 13 different days. 190 
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The clinical validation was conducted using blood samples from 24 healthy volunteers as per 191 
Section 2.2. Results from DBS or liquid whole blood were converted to retinol content per 192 
plasma sample using the average haematocrit value (erythrocyte percentage: male 45%, 193 
female 40%) for the purposes of comparison. Scatter plots were drawn to determine 194 
correlations using Microsoft Excel 2010. 195 
2.10. Statistical analyses 196 
Unless indicated otherwise, all data reported are the mean of triplicate determinations with 197 
standard deviation. Treatment group comparisons were made using one-way ANOVA by 198 
IBM SPSS Statistics 21. The least significant p value was set at <0.05. In method comparison, 199 
Pearson correlation coefficient was calculated with significance p value, and additional 200 
Bland-Altman test was conducted to check the bias using GraphPad Prism 6 v007. 201 
3. Results and Discussion 202 
3.1. Effect of paper pre-treatment with antioxidants  203 
We initially evaluated the retinol stability by using samples of a stock plasma sample dried 204 
on Whatman 903
®
 filter paper. We included the antioxidant BHT as well as the chelating 205 
reagents EDTA and ascorbic acid to test if they improved the recovery of retinol from the 206 
paper. Compared to the reference value, adding the antioxidant BHT resulted in no increase 207 
in retinol recovery (Fig. 1). On the other hand, the chelating agent EDTA gave higher 208 
recovery but still resulted in around 20% losses. However, in the presence of ascorbic acid, 209 
retinol recovery increased markedly. This improved recovery of retinol was not influenced by 210 
the additional presence of BHT (Fig 1).  We then tested different concentrations of ascorbic 211 
acid in order to optimise the ratio of ascorbic acid to retinol. The result showed that 212 
concentrations between 1.25 mg/mL and 5 mg/mL ascorbic acid were sufficient to prevent 213 
losses in retinol recovery (Fig. 2). Levels of ascorbic acid above 10 mg/mL resulted in lower 214 
retinol recovery. Although ascorbic acid was added in a method reported previously [15] the 215 
high dose of ascorbic acid used (10 mg/mL) might have inhibited retinol extraction. 216 
3.2. Effect of acid on the extraction of retinol from dried plasma spot 217 
We addressed the question of whether the effect of ascorbic acid was due to the fact that it 218 
was a weak acid and whether other weak acids might have a similar effect by facilitating a 219 
higher retinol recovery. Some other organic acids tested (oxalic acid, citric acid) were less 220 
effective (≈ 80% recovery) than ascorbic acid. However, when we introduced 2mM (0.12 221 
mg/mL) acetic acid into the extraction solvent it resulted in close to 100% recovery (Fig. 3). 222 
The effect of acetic acid was unaffected by the presence of BHT or ascorbic acid. We 223 
concluded that acidic conditions increased the extraction of retinol from the paper since it 224 
was unlikely that acetic acid could have any antioxidant activity.  225 
It is unclear why acidic conditions during extraction give close to 100% retinol recovery. We 226 
hypothesise that reasons could involve the dissociation of retinol from its binding protein in 227 
acidic conditions which increases retinol abundance during extraction. This is supported by 228 
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the findings of Guy et al [17] who reported that urinary retinol binding protein is pH 229 
dependent, and is most unstable at pH 5-7.  230 
3.3. Stability of retinol in DBS 231 
A comparison between the recovery of retinol from DBS using our method and a previously 232 
published method [15] over time is shown in Fig. 4. In our hands the published method 233 
resulted in a retinol loss of 18.3% (Fig. 4), which is similar to their reported percentage loss 234 
(23%) [15]. In contrast, our method showed a consistent recovery of 93.2% even after day 33. 235 
The results confirmed that using acidic extraction, retinol can be extracted from whole blood 236 
dried on 903
®
 filter paper with minimum loss. 237 
We conducted a more detailed time course stability experiment using DBS at room 238 
temperature (≈ 25 °C) in foil bags with desiccants. As shown in the Table, with our acidic 239 
extraction method, retinol in DBS was stable (<5% relative loss to conventional 2-phase 240 
extraction of liquid blood) for up to 10 weeks. In contrast to  previous reports [9, 10], we 241 
found no difference in stability between samples with and without BHT. This further 242 
indicates that, if stored in dark, dry conditions with minimum exposure to air, retinol in DBS 243 
can remain stable at room temperature for up to 10 weeks.  244 
3.4. Linearity and precision 245 
Within the range of 0.05 – 2 µg/mL the retinol standard curve was linear (Fig. 5). The slope 246 
(1.02) and intercept (-0.01) were close to the mathematical model y=x, which indicates that 247 
retinol concentrations measured are identical to standards that were injected directly into 248 
HPLC. The correlation between total retinol concentrations in DBS containing spiked 249 
standards against concentrations by direct injection was R
2
=0.9939. The intercept showed the 250 
concentration of endogenous retinol in the DBS samples was 0.85 μg/mL (1.83 μM). The 251 
total retinol concentrations in DBS with spiked standards were positively and linearly 252 
proportional to the concentration of direct retinol injection. The extraction recovery was 253 
calculated by the ratio of retinol to original added amount and was 86% - 116%.  254 
To test the precision of the assay, aliquots of the same plasma sample were measured both 255 
within a day (n=6) or between different days of a month (n=13). Intra-day coefficient of 256 
variation was 1.7% with a mean of 2.02 ± 0.03 μg/mL (mean ± SD), and inter-day variation 257 
was 6.2% with a mean of 2.13 ± 0.13 μg/mL (mean ± SD).  258 
The limit of quantification was defined as the value obtained when the retinol peak height 259 
was 10 times higher than baseline. With this definition, the cut-off value for LOQ was 0.05 260 
μg/mL (0.175 μM), which is satisfactory for biological samples even with vitamin A 261 
deficiency (usually considered as lower than 0.2 μg/mL, or 0.7 μM [18]). 262 
3.5. Clinical validation of the DBS method 263 
Blood samples collected three ways (finger capillary blood dried on paper, venous blood 264 
dried on paper, and venous plasma extracted with 2-phase solvent extraction) from 24 265 
subjects were compared. 266 
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Fig. 6 shows that there are positive linear correlations between capillary blood, venous blood 267 
and venous plasma retinol values (rA= 0.9724, rB= 0.9538, rC= 0.9398). This is in agreement 268 
with other dried blood methods showing minimal differences in retinol levels between finger 269 
blood and venous blood/plasma [19]. 270 
We acknowledge that between individuals the haematocrit values may vary as a result of 271 
biological variation and dehydration levels. Also the precision of relating punch size to blood 272 
volume in practical situations can be dependent on the quality of DBS collected. However 273 
with the proper training of blood collection staff, and the average haematocrit value, our DBS 274 
method is satisfactory for large-scale population level studies. It also proved to be practical 275 
when values are compared with the matched plasma samples (Fig. 6).   276 
Complex and expensive steps including venipuncture, centrifugation and refrigerated 277 
transport of samples [20] add to the expense of screening large numbers of people for vitamin 278 
A deficiency. Because the DBS system does not require trained phlebotomists, and no 279 
centrifugation or refrigeration is required, the system is ideally suited for large scale 280 
population studies regardless of location. Even though our DBS method requires that the 281 
DBS sample must softened before extraction and the solvent acidified, these factors are more 282 
than offset by the convenience of being able to take, transport and store samples without 283 
refrigeration.  284 
4. Conclusions: 285 
Endogenous retinol in both plasma and whole blood dried on Whatman 903
®
 filter paper is 286 
stable (under dark and dry conditions) for periods up to 10 weeks without refrigeration. 287 
Acidified methanol is required to maximise retinol extraction efficiency during sample 288 
processing. This simple and reliable method for the determination of vitamin A status is 289 
particularly valuable for population studies and large clinical trials.  290 
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Table 1. Stability of retinol on Dried Blood Spot (DBS) over 10 weeks. 356 
     Days 
Conc.  
(μg/mL) 







































# No pre-treatment was applied on 903
®
 paper. 357 
* BHT (Butylated hydroxytoluene) was pre-treated on 903
®
 filter paper, the amount being 0.35 mg.  358 
Concentrations are shown as mean ± SD (n=3). No significant differences were detected (one-way 359 
ANOVA, sig. level set at p<0.05). 360 
 361 
  362 
13 
 
  363 
Fig. 1. Recovery of retinol (mean ± SD; n=3) from dried plasma spots pre-treated with various 364 
protectants after 4 hours drying at room temperature in darkness. The values of retinol recovery% are 365 
referring to plasma 2-phase extraction. Control: 50 μL plasma spotted on blank 903® paper; BHT 366 
(Butylated hydroxytoluene): 50 μL plasma spotted on 903® paper pre-treated with 0.25 mg BHT; 367 
EDTA (Ethylenediaminetetraacetic acid): 50 μL plasma spotted on 903® paper pre-treated with 0.25 368 
mg EDTA; BHT+EDTA: 50 μL plasma spotted on 903® paper pre-treated with 0.25 mg BHT and 369 
0.25 mg EDTA; Asc (Ascorbic acid): 50 μL plasma spotted on 903® paper pre-treated with 0.25 mg 370 
ascorbic acid; BHT+ Asc: 50 μL plasma spotted on 903® paper pre-treated with 0.25 mg BHT and 371 
0.25 mg ascorbic acid. . Different letters indicate significant differences (p<0.05) using one-way 372 
ANOVA and post-hoc Duncan test. 373 






























Fig. 2. Retinol stability (mean ± SD; n=3) from dried plasma spot with different doses of ascorbic 376 
acid (Asc) stored in aluminium foil bags with desiccants. The values of retinol recovery% are 377 
referring to plasma 2-phase extraction. Control: 50 μL plasma spotted on blank 903® paper; Asc 0.13: 378 
50 μL plasma spotted on 903® paper pre-treated with 0.13 mg ascorbic acid; Asc 0.25: 50 μL plasma 379 
spotted on 903
®
 paper pre-treated with 0.25 mg ascorbic acid; Asc 0.5: 50 μL plasma spotted on 903® 380 
paper pre-treated with 0.5 mg ascorbic acid; Asc 1: 50 μL plasma spotted on 903® paper pre-treated 381 
with 1 mg ascorbic acid. Triplicates were included for each group. Different letters over the bars 382 
indicate significant differences (p<0.05) using one-way ANOVA post-hoc Duncan test. 383 































Fig. 3. Retinol recovery (mean ± SD; n=3) from dried plasma spots using different extraction 386 
conditions with or without acetic acid (HAc). HAc concentrations: 2mM. Dried plasma spots were 387 
extracted after 4 h drying; the percentages were related to plasma 2-phase extraction. Control: 50 μL 388 
plasma spotted on 903
®
 filter paper without pre-treatment. Ascorbic: 50 μL plasma spotted on 903® 389 
paper pre-treated with 0.25 mg ascorbic acid. BHT (Butylated hydroxytoluene): 50 μL plasma spotted 390 
on 903
®
 paper pre-treated with 0.25 mg BHT. Different letters indicate significant differences (p<0.05) 391 
using one-way ANOVA and post-hoc Duncan test. 392 
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Fig. 4. Stability of retinol on dried blood spots (DBS) stored at room temperature over 33 days with 395 
two extraction methods. DBS-Reported method: Referring to the method published in literature [15]; 396 
DBS-Optimised method: method used in this study. Triplicates were included for each group. 397 
Statistical analyses were conducted using one-way ANOVA and post-hoc Duncan test. Significant 398 
differences were found between the two methods on day 19 (* p=0.010) and day 33 (
#
 p=0.013). 399 



























Fig. 5. Linearity of DBS spiked with serially diluted retinol standard solutions extracted with our 402 
modified method compared with direct injection of standard solutions. The intercept shows the 403 
concentration of endogenous retinol in the DBS samples being 0.85 μg/mL (1.83 μM).  404 
  405 
y = 1.0594x + 0.8538 
R² = 0.9939 
y = 1.0208x - 0.0143 

































  406 
Fig. 6. Linear correlation of retinol concentration between dried blood spots from finger (capillary 407 
DBS), venous blood and venous plasma from 24 healthy subjects. A, Finger DBS against Venous 408 
DBS; B, Finger DBS against Venous Plasma; C, Venous DBS against Venous Plasma.  Extraction of 409 
DBS was conducted using our acidified DBS extraction method. Retinol concentrations were 410 
converted to the equivalent amount in plasma according to average haematocrit (male 45% 411 
erythrocytes, female 40%). Pearson correlation coefficients were calculated for each plot with p (2-412 
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